FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...

Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- ...

Reimbursement through Medicare/Medicaid represents approximately 50% of covered lives in target population WALTHAM, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a ...

Product-specific Q Code (Q0224) facilitates product reimbursement for PEMGARDA; corresponding M Code (M0224) defines reimbursement for product administration Reimbursement through Medicare/Medicaid ...

The Medicare Inpatient Only (IPO) list details the procedures that Medicare will cover in an inpatient setting. The Centers for Medicare & Medicaid Services (CMS) releases the IPO list each year. The ...

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Critical & Chronic Care Solutions Division announced today that the Centers for Medicare and Medicaid Services (CMS) has assigned product-specific Healthcare ...

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...

, (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is pleased to announce today ...

The 2019 version of the Healthcare Common Procedure Coding System Level II code set for reporting supplies and services to public and private insurers took effect Jan. 1. The code set includes updates ...